Haibu Pharmaceutical has been awarded the "Top 50 Pharmaceutical R&D Companies in China" for consecutive years.
Classification:
Company News
Release time:
2023-09-18
On July 4, 2023, the "2022-2023 Annual Release Conference of the Most Influential List in China's Pharmaceutical Industry · The 15th China Pharmaceutical Industry Development Summit Forum" was grandly held in Harbin, co-hosted by the National Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, Heilongjiang Provincial Federation of Industry and Commerce, and Heilongjiang Provincial Development and Reform Commission. The conference focused on "Promoting High-Quality Development of the Industry and Revitalizing Northeast Medicine," interpreting policies and discussing hot topics in the pharmaceutical industry from different perspectives. Under the background of the "Healthy China" strategy, it addressed the opportunities and challenges faced by the pharmaceutical industry.
The China Pharmaceutical Industry Development Summit Forum is one of the highest-level and most influential industry events. It aims to guide entrepreneurs in the pharmaceutical industry to operate honestly and legally, using the chamber of commerce as a hub to gather advantageous resources for high-quality development in the pharmaceutical industry, promote deep integration of industrial chains, advance technological innovation among member enterprises, and foster specialized and innovative development. This will continuously enhance innovative thinking and developmental thinking, promoting high-quality development for enterprises as a whole.
Haibu Pharmaceutical has been awarded "Top 50 Chinese Pharmaceutical R&D Companies" for consecutive years.
Beijing Hope Pharmaceutical Co., Ltd.
